Objective Proton magnetic resonance spectroscopy ( 1 H-MRS) enables the clinician to noninvasively assess the amount of ectopic fat in the liver, skeletal muscle and myocardium. Recent studies have reported that the myocardial triglyceride (TG) content is associated with aging, metabolic disorders and cardiac dysfunction. However, the clinical usefulness of myocardial TG measurements in Japanese subjects has not been fully investigated. Methods The myocardial TG content was evaluated using 1 H-MRS in 37 apparently healthy Japanese subjects, and the left ventricular function was measured on cardiac magnetic resonance imaging (MRI). Blood pressure, body composition and biochemical markers were measured in a fasting state, and cardiopulmonary exercise testing (CPX) was performed to evaluate exercise capacity. Results The mean myocardial TG content was 0.85±0.40%. The myocardial TG content was significantly associated with the percent body fat (r=0.39), serum triglyceride level (r=0.40), estimated glomerular filtration rate (r=-0.37), anaerobic threshold (r=-0.36), maximal load of CPX (r=0.39), left ventricular enddiastolic volume (r=-0.41) and left ventricular end-systolic volume (LVESV) (r=-0.51) (all: p<0.05). In a multivariate analysis, the LVESV was found to be an independent factor of the myocardial TG content.
Introduction
Ectopic fat is associated with obesity as well as various metabolic disorders and cardiovascular diseases (1) (2) (3) . In animal studies, elevated myocardial triglyceride (TG) levels that the myocardial TG content measured using 1 H-MRS is associated with age (6) and the presence of diabetes mellitus (7) and myocardial systolic dysfunction (4, 8, 9) or diastolic dysfunction (6, 10) . In addition, progressive caloric restriction has been shown to induce a dose-dependent increase in the myocardial TG content (11) , whereas endurance training reduces this parameter (12) . We recently reported that the myocardial TG content is significantly lower in endurance athletes than in healthy subjects (13) .
The aim of this study was to assess the associations between the myocardial TG content measured on 1 H-MRS and metabolic parameters, cardiac morphology, the left ventricular function and exercise capacity in apparently healthy Japanese subjects.
Materials and Methods

Subjects
A total of 37 apparently healthy Japanese men were recruited through a local advertisement. All subjects were 20-61 years of age and not currently receiving any medical treatment. Individuals with findings of acute or chronic diseases on a medical examination were excluded. The ethics committee of Juntendo University approved the study protocol and all subjects provided their written informed consent before participating in this study, according to the guidelines of the Declaration of Helsinki.
Measurements
Body composition was assessed in terms of skeletal muscle mass and body fat after overnight fasting using a multifrequency bioelectrical impedance analysis with eight tactile electrodes (MF-BIA8; In-Body 720, Biospace, Seoul, Korea) (14) . The subject's apparatus provides measurements of the fat mass, fat-free mass and percentage body fat. Each patient's personal activity level was assessed using the international physical activity questionnaire (IPAQ) (15) .
Standard laboratory tests were performed under fasting conditions before the 1 H-MRS procedure. Serum lipid profiles were determined according to enzymatic methods, including the total cholesterol (Symex, Kobe, Japan), highdensity lipoprotein (HDL) cholesterol and triglyceride (Sekisui Medical, Tokyo, Japan) levels, using a BioMajesty JCA-BM8060 analyzer (Japan Electron Optics Laboratory, Tokyo, Japan). The Friedewald formula was used to calculate the level of serum low-density lipoprotein (LDL) cholesterol. The serum insulin level was assessed using a chemiluminescent enzyme immunoassay with the Lumipulse presto II analyzer (Fujirebio, Tokyo, Japan). The homeostasis model assessment index (HOMA-IR) was calculated to estimate the degree of insulin resistance based on the fasting insulin and glucose levels, as follows: insulin (μU/mL) × glucose (mmol/L)/22.5 (16) . The free fatty acid (FFA) level was measured using a standard assay (Eiken chemical, Tokyo, Japan) and BioMajesty JCA-BM2250 analyzer (Japan Electron Optics Laboratory, Tokyo, Japan). The serum Nterminal pro-brain natriuretic peptide (NT-proBNP) level was determined using an electrostatically controlled linear inchworm actuator on modular analytics (HITACHI HiTechnologies, Tokyo, Japan). Finally, the HbA1c level was determined in whole-blood samples according to a latexenhanced immunoassay (Fujirebio, Tokyo, Japan).
MRI and MRS
Cardiac magnetic resonance imaging (MRI) and 1 H-MRS were conducted on a MAGNETOM Avanto 1.5-Tesla MRI system (Siemens Medical Solution, Erlangen, Germany), as previously reported (13) . In brief, each subject rested in the supine position with a belt placed around the upper part of the abdomen in order to minimize respiratory movements. LV functional and morphological parameters were determined using a specially designed software program (Argus; Siemens Medical Systems, Erlangen, Germany) (17, 18) on a separate workstation. The endocardial and epicardial LV borders were traced manually on short-axis cine images obtained at end-systole and end-diastole. The LV end-diastolic volume (EDV), LV end-systolic volume (ESV), LV ejection fraction and stroke volume were calculated using Simpson's method. Furthermore, the peak LV ejection and filling rates were automatically derived from LV volume-time curves.
In order to quantify the myocardial TG content, a 10×10× 20-mm 3 voxel was positioned within the ventricular septum on cine dynamic cine-mode images (Fig. 1 ). The spectrum of water and lipids was acquired using point-resolved spectroscopy (PRESS) with a repetition time (TR) of at least 4,000 ms and echo time (TE) of 30 ms. The myocardial TG signals were acquired at 1.4 ppm from water suppressed spectra. The water signals were acquired at 4.7 ppm from non-water suppressed spectra (Fig. 1 ). The areas under the curves for the water and lipid peaks were quantified according to standard line-fitting procedures (Siemens Syngo Spectroscopy, Siemens Medical Solution). The myocardial TG levels are expressed as the lipid to water ratios (%) (13, (19) (20) (21) .
Measurement of cardiopulmonary fitness
An incremental cycling test was performed on a Corival 400 (Lobe B.V., Groningen, Netherlands) with an expiratory gas analyzer (Vmax-295, SensorMedics, Yorba Linda, USA) in order to measure the anabolic threshold (AT) and maximal oxygen consumption (VO2max), as previously described (22) . After three minutes of rest, a three-minute warm-up test was performed at 40 W, followed by ramp loading (15-30W/min) until subjective exhaustion. According to the American Thoracic Society/American College of Chest Physicians (ATS/ACCP) guidelines, AT corresponds to the change in slope midrange of the VO2/VCO2 response curve (V-slope method). In cases in which the AT point was not identified on the V-slope, we used the point at which VE/VO2 starts to increase while VE/VCO2 remains constant, with VE corresponding to the total minute ventilation (23). 
Evaluation of atherosclerotic parameters
The parameter of atherosclerosis, the cardio-ankle vascular index (CAVI), was calculated automatically using the VaSera VS-1500 AN ( Fukuda Denshi, Tokyo, Japan) (24, 25) .
Statistical analysis
The values are expressed as the mean ± standard deviation (SD). Variables not exhibiting a normal distribution were transformed into natural logarithmic values prior to the statistical analyses. Pearson's correlation coefficients were calculated between the myocardial TG content and the other parameters. In order to assess determinants of the myocardial TG content, we performed univariate and multivariable linear regression analyses. All statistical analyses were conducted using the SPSS version 20 software package (SPSS, Chicago, USA). A p value of less than 0.05 was considered to be statistically significant. 
Results
The clinical characteristics of the study subjects are summarized in Table 1 . The mean age was 30.5±8.1 years, the mean body mass index was 22.7±2.0 kg/m 2 and the mean maximum VO2 was 43.2±8.0 mL/kg/min. None of the subjects were obese or had abnormal parameters on the blood analyses.
The MRI and MRS variables are shown in Table 2 . None of the subjects had an abnormal ejection fraction, cardiac mass volume, peak ejection fraction or filling rate. The myocardial TG content was positively correlated with the percent body fat (r=0.39, p=0.02) and serum TG level (r= 0.35, p=0.001) (Fig. 2 ) and negatively correlated with the estimated glomerular filtration rate (eGFR; r=-0.37, p=0.02), AT (r=-0.36, p=0.02), maximal load of cardiopulmonary exercise testing (CPX) (r=-0.40, p=0.01), left ventricular enddiastolic volume (LVEDV; r=-0.42, p=0.01) and left ventricular end-systolic volume (LVESV; r=-0.51, p=0.01) (Fig. 3) . No significant correlations were noted between the myocardial TG content and the CAVI (r=0.16, p=0.37) or and the IPAQ score (r=-0.25, p=0.14).
The AT level strongly correlated with the maximal CPX load (r=0.81, p<0.0001). The LVESV level also correlated with the LVEDV (r=0.82, p<0.0001). Moreover, the myocardial TG content and serum TG level were associated with insulin resistance and obesity, and the relationship between the myocardial TG content and the eGFR was affected by aging. Therefore, we performed a multivariate analysis including age, BMI, serum TG, eGFR and LVESV. In this model, the LVESV was an independent factor of the myocardial TG content (Table 3) .
Discussion
The present study demonstrated significant associations between the myocardial TG content and the percent body fat, serum TG level, eGFR, anaerobic threshold, maximal load of CPX, LVEDV and LVESV in apparently healthy Japanese subjects. In addition, the LVESV value was found to be an independent factor of the myocardial TG content.
The generation of myocardial TG is closely dependent on myocardial lipid metabolism. The accumulation of myocardial TG is primarily determined by the supply of the fatty acids and mitochondrial energy-producing efficiency (26) . Moreover, myocardial lipid metabolism is regulated by a complex equilibrium between the supply of fatty acids to the heart, competing energy substrates, energy demand and supply of oxygen to the heart, uptake and esterification of fatty acids and control of the mitochondrial function (i.e. fatty acid oxidation and electron transport chain activity) (26) . Therefore, it is important to assess the myocardial TG content using 1 H-MRS noninvasively in the clinical setting.
Previous studies have reported that the myocardial TG content is related to obesity, metabolic disorders and cardiac dysfunction (1, 2, 4, 5, 7, 27) . The present study confirmed an association between the myocardial TG content and parameters of metabolic disorders, including the percent body fat and serum TG levels, even in apparently healthy subjects. These associations are supported by the wellestablished notion that increased body fat results in insulin resistance and high TG levels. In addition, a previous study suggested that the myocardial TG content is associated with obesity via a positive association with the plasma FFA concentration (8) . However, we found no correlations between the FFA level and myocardial TG content in our healthy subjects (data not shown). The present study subjects did not include obese patients or those with impaired glucose tolerance with a decreased mitochondrial function. In addition, we enrolled several healthy subjects with exercise habits. Endurance exercise regulates lipoprotein lipase synthesis and the mitochondrial function, primarily β-oxidation (28). The background factors of the study subjects may therefore account for differences in results between the present study and previous reports.
In the current analysis, we found that morphological cardiac parameters were negatively correlated with the myocardial TG content, including the LVEDV and LVESV. In previous reports, the myocardial TG content has been shown to positively correlate with LV mass weight per LV volume according to the degree of LV hypertrophy (4). Furthermore, we recently reported that athletes exhibit lower myocardial TG levels (13) . We also included several endurance athletes in the present study; however, similar trends were obtained after excluding these subjects (data not shown). Moreover, the LVESV level was found to be an independent predictor of the myocardial TG content. These data suggest that measuring the myocardial TG content is useful for assessing the relationship between cardiac remodeling and cardiac lipid metabolism, although further investigations are needed to clarify the precise mechanisms.
Finally, our data showed a negative correlation between the myocardial TG content and AT. A previous study demonstrated a negative relationship between the myocardial TG content and cardiopulmonary fitness in obese women (27) . Reduced cardiorespiratory fitness predisposes to individuals to cardiovascular disease and predicts premature death (29, 30) , and the level of cardiorespiratory fitness de-pends on both the degree of obesity and age. Our next study will investigate the impact of clinical interventions on the myocardial TG content and exercise tolerance.
The present study is associated with several limitations. First, this was a single-center study with a small sample size. Second, we included only male subjects. Finally, we did not perform oral glucose tolerance tests. Therefore, some subjects with impaired glucose tolerance may have been included in our study population; however, no obese individuals or patients with impaired glucose tolerance with an obviously decreased mitochondrial function were assessed.
Conclusion
1 H-MRS may be useful for noninvasively assessing the associations between the myocardial TG content and various clinical parameters, including those indicative of obesity, metabolic disorders, cardiac morphology and exercise capacity, even in healthy Japanese subjects.
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